Arunjyoti Bio Ventures Ltd (ABVL)

Loading page…

Arunjyoti Bio Ventures Ltd (ABVL) · mywealthgrid

About

Arunjyoti Bio Ventures Ltd operates in Other Financial Services within the Financials sector.

Face value: ₹1

Market cap

₹75 Cr

P/E

—

P/B

2.6×

Dividend yield

ROE

-14.9%

ROCE

-0.8%

Debt / equity

0.76

OPM

10.4%

EPS (TTM)

₹-0.1

Book value

₹1.5

52-week high

—

52-week low

—

556 historical price candles were omitted because the exchange source has not been verified.

₹4.00%1Y

Quick read

rule-based

Pros

+Revenue CAGR of 38.2% over the last 5 years

Cons

−Low return on equity of -14.5% (3-yr avg)
−Weak interest coverage of -0.2×

Research score

Structured signal from quality, growth, valuation and momentum.

39/100

Business quality: 16
Growth: 33
Valuation: 69

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Crisil LimitedCRISILCRISIL	₹32,373 Cr	₹32,373 Cr	₹4,126 Cr	₹1,229 Cr	29.7%	₹884 Cr	21%	33.9%	27.4%	48
RRP Semiconductor LtdRRPRRP	₹11,162 Cr	₹11,168 Cr	₹-7 Cr	₹-7 Cr	—	₹-8 Cr	—	-32.7%	-59.8%	—
Onemi Technology Solutions LimitedKISSHTKISSHT	₹6,254 Cr	₹7,346 Cr	₹2,179 Cr	₹651 Cr	29.9%	₹281 Cr	12.9%	32.9%	21%	-8
Asset Reconstruction Company (India) LimitedARCILARCIL	₹4,546 Cr	₹5,751 Cr	₹722 Cr	₹473 Cr	65.5%	₹-36 Cr	44.7%	—	-1.3%	—
Colab Platforms LtdCOLABCOLAB	₹2,622 Cr	₹2,624 Cr	₹158 Cr	₹2 Cr	1%	₹5 Cr	2.9%	23.2%	17.2%	9
Gyftr LtdGYFTRGYFTR	₹1,204 Cr	₹1,240 Cr	₹14 Cr	₹3 Cr	21.6%	₹2 Cr	12.9%	—	0.5%	—
Prime Securities LimitedPRIMESECUPRIMESECU	₹1,022 Cr	₹1,024 Cr	₹125 Cr	₹13 Cr	15.7%	₹5 Cr	9.6%	—	6.7%	—
Centrum Capital LimitedCENTRUMCENTRUM	₹969 Cr	₹17,026 Cr	₹3,643 Cr	₹948 Cr	29.2%	₹-217 Cr	-7.5%	12.7%	-46.8%	-519
Wealth First Portfolio Managers LimitedWEALTHWEALTH	₹952 Cr	₹952 Cr	₹58 Cr	₹37 Cr	72.3%	₹33 Cr	56%	34.5%	27.7%	563
Stellant Securities (India) LtdSTELLANTSTELLANT	₹518 Cr	₹518 Cr	₹0 Cr	₹-0 Cr	-93.8%	₹-0 Cr	-93.8%	-45.5%	-44.8%	0
The Investment Trust Of India LimitedTHEINVESTTHEINVEST	₹472 Cr	₹523 Cr	₹274 Cr	₹48 Cr	20.2%	₹33 Cr	12.2%	8.5%	4.2%	-42
Ndl Ventures LimitedNDLVENTURENDLVENTURE	₹422 Cr	₹1,328 Cr	₹1,044 Cr	₹149 Cr	17%	₹-38 Cr	0.2%	4.4%	-5.9%	-739

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	—	39	—	—	7	6	3	2	20	28	28
Interest	—	—	—	—	—	0	0	0	2	3	2
Expenses	0	39	0	4	7	5	3	2	18	23	25
Financing profit	—	—	—	—	—	0	-0	0	1	2	1
Financing margin %	—	—	—	—	—	1.6%	-6.7%	9.2%	3.3%	8.7%	3%
Other income	—	—	—	—	—	0	0	0	0	0	0
Depreciation	0	0	0	—	—	0	0	0	2	3	3
Exceptional items	—	—	—	—	—	—	—	—	0	0	-3
Profit before tax	-0	0	-0	0	0	0	0	0	-1	-0	-5
Tax	—	0	—	—	—	0	0	0	-1	1	-1
Tax %	—	16.7%	—	—	—	22.2%	25%	25%	-73.1%	435.3%	-11.7%
PAT	-0	0	-0	0	0	0	0	0	-0	-2	-5
EPS (₹)	—	1	-1.2	0.2	0.5	0.3	—	—	-1.7	-0.1	-0.2
EPS adjusted (₹)	—	—	—	—	—	0	0	0.1	-0.2	-0.1	-0.2
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	2	2	2	2	19	19
Reserves	-0	-0	0	-0	14	10
Minority interest	0	—	0	—	—	—
	0	0	32	51	26	22
	3	0	2	1	2	4
Total equity & liabilities	5	2	36	54	60	54
	0	0	0	41	43	42
CWIP	0	0	19	—	0	0
Investments	0	0	0	0	2	3
	5	2	17	13	15	9
Total assets	5	2	36	54	60	54

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-1	-13	6	1	10
	0	0	-19	-23	-6	-5
	0	0	32	17	5	-6
Net cash flow	-0	-1	0	0	1	-0
Free cash flow	—	—	-32	-17	-4	7
CFO / Operating profit %	-344.4%	—	—	228.6%	28.9%	359.7%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	15.2%	3.4%	13.8%	58.3%	81.2%	—
EBITDA margin %	—	1.6%	1.6%	-6.7%	9.2%	13.5%	18%	10.4%
EBIT margin %	—	1.6%	1.6%	-6.7%	9.2%	3.7%	7%	-1.7%
PAT margin %	—	1.5%	1.3%	2%	6.9%	-1.7%	-6.5%	-16.4%
Working capital
Receivable days	—	—	122	66	164	49	52	51
Inventory days	—	—	2	0	214	126	183	2
Payable days	—	—	102	3	0	17	0	26
NWC days	—	—	22	64	378	158	235	26
Leverage
Current ratio	—	—	1.16	12.11	3.64	1.51	2.8	0.43
Debt to EBITDA	—	—	0	—	201.69	18.39	5.11	7.55
Debt to equity	—	—	0	0	15.29	28.67	0.79	0.76
Interest coverage	—	—	—	—	—	0.4	0.9	-0.2
Asset turnover	—	—	1.17	1.41	0.05	0.38	0.47	0.51
Return ratios
Return on assets %	—	—	1.5%	2.9%	0.3%	-0.6%	-3.1%	-8.4%
Return on capital employed %	—	—	4.6%	4.1%	0.9%	2%	4.4%	-0.8%
Return on equity %	—	—	3.6%	3%	5.7%	-19.8%	-5.6%	-15.8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	48.97%	48.97%	61.79%	61.79%	61.79%	61.05%	47.64%	47.64%	47.64%	47.64%	47.64%	47.64%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	51.03%	51.03%	38.21%	38.21%	38.21%	38.95%	52.36%	52.36%	52.36%	52.36%	52.36%	52.36%
No. of shareholders	—	—	—	—	—	—	—	—	5,321	5,215	5,634	20,483

Promoter holding down 1.33 percentage points since Sep 2023.

50 deals · 25 May 2022 – 16 Apr 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
16 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	23,79,657	₹10.59	₹2.52 Cr
15 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	23,63,351	₹10.18	₹2.41 Cr
9 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	11,58,401	₹8.83	₹1.02 Cr
29 Aug 2025	SHASHANK SAI PABBATHI	Bulk	BSE	Buy	45,90,000	₹6.00	₹2.75 Cr
29 Aug 2025	MONIKA UDAY SHAH	Bulk	BSE	Sell	45,87,616	₹6.00	₹2.75 Cr
13 Dec 2024	P BADARI NARAYANA	Bulk	BSE	Sell	1,38,000	₹165.20	₹2.28 Cr
29 Apr 2024	AMIT DHANYAKUMAR CHORDIA	Bulk	BSE	Buy	1,53,000	₹64.99	₹0.99 Cr
29 Apr 2024	GLADISMENEZES	Bulk	BSE	Sell	93,299	₹64.99	₹0.61 Cr
29 Apr 2024	GLADISMENEZES	Bulk	BSE	Buy	15,000	₹59.95	₹0.09 Cr
6 Nov 2023	RAMESH LINGAMANENI	Bulk	BSE	Sell	17,694	₹195.65	₹0.35 Cr

1–10 of 50

1 / 5

Mr. PABATHI BADRI NARAYANA MURTHYExecutive Director-Chairperson
Mr. SRIKAR RANGANon-Executive - Independent Director
Mr. VIJAYA RAMA LAKSHMANA MURTHY MYLARAPUNon-Executive - Independent Director
Mr. NADIMPALLI VISHALExecutive Director
Mrs. DHANLAKSHMI GUNTAKANon-Executive - Independent Director
Mr. DATHVIK PABBATHIExecutive Director
Ms. Swati JainCompany Secretary cum Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Arunjyoti Bio Ventures Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Face value ₹10 → ₹117 Jan 2025 · ex-date

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

23 announcementsExport CSV

22 Sept 2026, 3:17 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

3 Sept 2026, 5:40 pmCompany Update

Announcement under Regulation 30 (LODR)-Change of Company Name

Change of Name PDF

12 Aug 2026, 6:56 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

12 Aug 2026, 6:52 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

20 Jul 2026, 5:15 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

20 Jul 2026, 5:02 pmAGM/EGM

Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 12.08.2026

AGM PDF

9 Jul 2026, 6:37 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

9 Jul 2026, 6:24 pmResult

Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 30.06.2026.

Financial Results PDF

Date	Category	Subject	Filing
22 Sept 2026, 3:17 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
3 Sept 2026, 5:40 pm	Company Update Change of Name	Announcement under Regulation 30 (LODR)-Change of Company Name	PDF

Loading announcements…

Arunjyoti Bio Ventures Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Stock splits1

Announcements

Ratio timeline

Not in the F&O segment

Stock splits1

No fund holdings on record

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

1

1